Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Not Confirmed
Not Confirmed
22-24 April, 2025
Not Confirmed
Not Confirmed
22-25 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
World Vaccine Conferen...World Vaccine Conference
Industry Trade Show
Not Confirmed
22-24 April, 2025
Industry Trade Show
Not Confirmed
22-25 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
01 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250401009688/en/Jerome-Stevens-Pharmaceuticals-Announces-Acquisition-of-Thyquidity-Levothyroxine-Sodium-Oral-Solution
Details:
Jerome acquires Thyquidity (levothyroxine sodium) from Azurity. It is indicated for the treatment of Hypothyroidism.
Lead Product(s): Levothyroxine Sodium
Therapeutic Area: Endocrinology Brand Name: Thyquidity
Study Phase: Approved FDFProduct Type: Hormone
Recipient: Azurity Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 01, 2025
Lead Product(s) : Levothyroxine Sodium
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Recipient : Azurity Pharma
Deal Size : Undisclosed
Deal Type : Acquisition
Jerome Announces Acquisition of Thyquidity (Levothyroxine Sodium Oral Solution)
Details : Jerome acquires Thyquidity (levothyroxine sodium) from Azurity. It is indicated for the treatment of Hypothyroidism.
Product Name : Thyquidity
Product Type : Hormone
Upfront Cash : Undisclosed
April 01, 2025
Regulatory Info : RX
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Jerome Stevens Pharmaceuticals
Dosage Form : CAPSULE;ORAL
Brand Name : BUTALBITAL, ASPIRIN, CAFF...
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 1998-08-31
Application Number : 74951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET;ORAL
Brand Name : ORPHENADRINE CITRATE, ASP...
Dosage Strength : 385MG;30MG;25MG
Packaging :
Approval Date : 1999-04-30
Application Number : 74988
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET;ORAL
Brand Name : ORPHENADRINE CITRATE, ASP...
Dosage Strength : 770MG;60MG;50MG
Packaging :
Approval Date : 1999-04-30
Application Number : 74988
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET;ORAL
Brand Name : METHOCARBAMOL AND ASPIRIN
Dosage Strength : 325MG;400MG
Packaging :
Approval Date : 1995-01-31
Application Number : 81145
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Jerome Stevens Pharmaceuticals
Dosage Form : CAPSULE;ORAL
Brand Name : CEPHALEXIN
Dosage Strength : EQ 250MG BASE
Packaging :
Approval Date : 1988-03-17
Application Number : 62870
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Jerome Stevens Pharmaceuticals
Dosage Form : CAPSULE;ORAL
Brand Name : CEPHALEXIN
Dosage Strength : EQ 500MG BASE
Packaging :
Approval Date : 1988-03-17
Application Number : 62869
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET;ORAL
Brand Name : CINACALCET HYDROCHLORIDE
Dosage Strength : 60MG
Packaging :
Approval Date : 2021-12-02
Application Number : 204364
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET;ORAL
Brand Name : CINACALCET HYDROCHLORIDE
Dosage Strength : 30MG
Packaging :
Approval Date : 2021-12-02
Application Number : 204364
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET;ORAL
Brand Name : CINACALCET HYDROCHLORIDE
Dosage Strength : 90MG
Packaging :
Approval Date : 2021-12-02
Application Number : 204364
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET;ORAL
Brand Name : DEFERASIROX
Dosage Strength : 360MG
Packaging :
Approval Date : 2019-12-27
Application Number : 210727
Regulatory Info : DISCN
Registration Country : USA
RLD : No
TE Code : AB
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Jerome Stevens Pharmaceuticals
Dosage Form : CAPSULE; ORAL
Proprietary Name : BUTALBITAL, ASPIRIN, CAF...
Dosage Strength : 325MG;50MG;40MG;30MG
Approval Date : 1998-08-31
Application Number : 74951
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET; ORAL
Proprietary Name : ORPHENADRINE CITRATE, AS...
Dosage Strength : 385MG;30MG;25MG
Approval Date : 1999-04-30
Application Number : 74988
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET; ORAL
Proprietary Name : ORPHENADRINE CITRATE, AS...
Dosage Strength : 770MG;60MG;50MG
Approval Date : 1999-04-30
Application Number : 74988
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET; ORAL
Proprietary Name : METHOCARBAMOL AND ASPIRI...
Dosage Strength : 325MG;400MG
Approval Date : 1995-01-31
Application Number : 81145
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Jerome Stevens Pharmaceuticals
Dosage Form : CAPSULE; ORAL
Proprietary Name : CEPHALEXIN
Dosage Strength : EQ 500MG BASE
Approval Date : 1988-03-17
Application Number : 62869
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Jerome Stevens Pharmaceuticals
Dosage Form : CAPSULE; ORAL
Proprietary Name : CEPHALEXIN
Dosage Strength : EQ 250MG BASE
Approval Date : 1988-03-17
Application Number : 62870
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET; ORAL
Proprietary Name : CINACALCET HYDROCHLORIDE
Dosage Strength : 30MG
Approval Date : 2021-12-02
Application Number : 204364
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET; ORAL
Proprietary Name : CINACALCET HYDROCHLORIDE
Dosage Strength : 60MG
Approval Date : 2021-12-02
Application Number : 204364
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET; ORAL
Proprietary Name : CINACALCET HYDROCHLORIDE
Dosage Strength : 90MG
Approval Date : 2021-12-02
Application Number : 204364
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Jerome Stevens Pharmaceuticals
Dosage Form : TABLET; ORAL
Proprietary Name : DEFERASIROX
Dosage Strength : 90MG
Approval Date : 2019-12-27
Application Number : 210727
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Inspections and registrations
ABOUT THIS PAGE